CDKN2A: The IVS2-105A/G Intronic Mutation Found in an Italian Patient Affected by Eight Primary Melanomas

This publication has 11 references indexed in Scilit:

• A deep intronic mutation in CDKN2A is associated with disease in a subset of melanoma pedigrees
  Human Molecular Genetics, 2001
• MC1R Genotype Modifies Risk of Melanoma in Families Segregating CDKN2A Mutations
  American Journal of Human Genetics, 2001
• The genetics of hereditary melanoma and nevi
  Cancer, 1999
• Mutation of the CDKN2A 5' UTR creates an aberrant initiation codon and predisposes to melanoma
  Nature Genetics, 1999
• The alternative product from the human CDKN2A locus, p14ARF, participates in a regulatory feedback loop with p53 and MDM2
  The EMBO Journal, 1998
• The Ink4a Tumor Suppressor Gene Product, p19Arf, Interacts with MDM2 and Neutralizes MDM2's Inhibition of p53
  Cell, 1998
• Affected members of melanoma‐prone families with linkage to 9p21 but lacking mutations in CDKN2A do not harbor mutations in the coding regions of either CDKN2B or p19 ^ARF
  Genes, Chromosomes and Cancer, 1997
• Compilation of somatic mutations of theCDKN2 gene in human cancers: Non-random distribution of base substitutions
  Genes, Chromosomes and Cancer, 1996
• A Cell Cycle Regulator Potentially Involved in Genesis of Many Tumor Types
  Science, 1994
• Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers
  Nature, 1994